Contraception News and Research

RSS
Digital birth control app gets FDA nod

Digital birth control app gets FDA nod

Study finds increased rate of repeat pregnancies in women with intellectual and developmental disabilities

Study finds increased rate of repeat pregnancies in women with intellectual and developmental disabilities

FDA permits marketing of first mobile medical app for contraceptive use to prevent pregnancy

FDA permits marketing of first mobile medical app for contraceptive use to prevent pregnancy

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first therapy for patients with rare tumors of the adrenal gland

FDA approves first therapy for patients with rare tumors of the adrenal gland

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Combe announces launch of Preventeza Emergency Contraceptive and campaign

Combe announces launch of Preventeza Emergency Contraceptive and campaign

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

‘Where the need is’: Tackling teen pregnancy with a midwife at school

‘Where the need is’: Tackling teen pregnancy with a midwife at school

Syphilis and gonorrhea on the rise in England

Syphilis and gonorrhea on the rise in England

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Podcast: KHN’s ‘What the Health?’ Campaign promises kept, plus ‘nerd reports’

Podcast: KHN’s ‘What the Health?’ Campaign promises kept, plus ‘nerd reports’

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

FDA approves new drug to treat MS in pediatric patients

FDA approves new drug to treat MS in pediatric patients

Study examines Internet-delivered intervention to reach woman at risk for drinking during pregnancy

Study examines Internet-delivered intervention to reach woman at risk for drinking during pregnancy

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

A potential "male pill" without side effects

A potential "male pill" without side effects